AR033554A1 - Un compuesto derivado de quinolina, su uso, procedimientos para su preparacion, y un medicamento que lo comprende - Google Patents

Un compuesto derivado de quinolina, su uso, procedimientos para su preparacion, y un medicamento que lo comprende

Info

Publication number
AR033554A1
AR033554A1 ARP010103784A ARP010103784A AR033554A1 AR 033554 A1 AR033554 A1 AR 033554A1 AR P010103784 A ARP010103784 A AR P010103784A AR P010103784 A ARP010103784 A AR P010103784A AR 033554 A1 AR033554 A1 AR 033554A1
Authority
AR
Argentina
Prior art keywords
alkyl
hydrogen
cycloalkyl
haloalkyl
compounds
Prior art date
Application number
ARP010103784A
Other languages
English (en)
Spanish (es)
Inventor
Chris Allen Broka
Woongki Kim
David Bernard Smith
Kevin Lee Mclaren
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR033554A1 publication Critical patent/AR033554A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP010103784A 2000-08-09 2001-08-08 Un compuesto derivado de quinolina, su uso, procedimientos para su preparacion, y un medicamento que lo comprende AR033554A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22419600P 2000-08-09 2000-08-09

Publications (1)

Publication Number Publication Date
AR033554A1 true AR033554A1 (es) 2003-12-26

Family

ID=22839655

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103784A AR033554A1 (es) 2000-08-09 2001-08-08 Un compuesto derivado de quinolina, su uso, procedimientos para su preparacion, y un medicamento que lo comprende

Country Status (15)

Country Link
US (2) US7049325B2 (cg-RX-API-DMAC7.html)
EP (1) EP1313707B1 (cg-RX-API-DMAC7.html)
JP (1) JP3930428B2 (cg-RX-API-DMAC7.html)
KR (1) KR20030027016A (cg-RX-API-DMAC7.html)
CN (1) CN1199950C (cg-RX-API-DMAC7.html)
AR (1) AR033554A1 (cg-RX-API-DMAC7.html)
AT (1) ATE367379T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001277560A1 (cg-RX-API-DMAC7.html)
BR (1) BR0113175A (cg-RX-API-DMAC7.html)
CA (1) CA2418832A1 (cg-RX-API-DMAC7.html)
DE (1) DE60129445T2 (cg-RX-API-DMAC7.html)
ES (1) ES2290161T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA03001178A (cg-RX-API-DMAC7.html)
WO (1) WO2002012192A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200300847B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW591089B (en) * 2001-08-09 2004-06-11 Cheil Ind Inc Slurry composition for use in chemical mechanical polishing of metal wiring
GB0220953D0 (en) * 2002-09-10 2002-10-23 Novartis Ag Organic compounds
US7132432B2 (en) * 2003-06-05 2006-11-07 Bristol-Myers Squibb Company Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
JP5667745B2 (ja) * 2005-03-08 2015-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 大環状化合物を製造する方法
AU2009293493B2 (en) * 2008-09-17 2014-09-18 Boehringer Ingelheim International Gmbh Combination of HCV NS3 protease inhibitor with interferon and ribavirin
CN102596201A (zh) 2009-10-30 2012-07-18 贝林格尔.英格海姆国际有限公司 包含BI201335、干扰素α和利巴韦林的HCV组合治疗的用药方案
US9383448B2 (en) 2012-07-05 2016-07-05 Deca System Co., Ltd. Golf GPS device with automatic hole recognition and playing hole selection
CN117924243B (zh) * 2024-01-16 2025-09-12 沈阳药科大学 一种喹啉衍生物及其药用组合物和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018134D0 (en) 1989-09-29 1990-10-03 Ici Plc Heterocyclic derivatives
ATE156120T1 (de) 1991-02-07 1997-08-15 Roussel Uclaf Bizyklische stickstoffverbindungen, ihre herstellung, erhaltene zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
MX9200299A (es) 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
GB9311790D0 (en) * 1993-06-08 1993-07-28 Minnesota Mining & Mfg Photothermographic materials
DK122693D0 (da) 1993-10-29 1993-10-29 Hempels Skibsfarve Fab J C Marin struktur
EP0830133A1 (en) * 1995-04-28 1998-03-25 Takeda Chemical Industries, Ltd. Therapeutic composition for arthritis
DE19638484A1 (de) * 1996-09-20 1998-03-26 Basf Ag Hetaroylderivate
DE19638486A1 (de) * 1996-09-20 1998-03-26 Basf Ag Hetaroylderivate
US6069151A (en) 1996-11-06 2000-05-30 Darwin Discovery, Ltd. Quinolines and their therapeutic use
IT1298159B1 (it) * 1997-01-28 1999-12-20 Hoffmann La Roche Derivati di un 5-aroilnaftalene
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6479438B2 (en) * 2001-01-04 2002-11-12 Isp Investments Inc. Gel inhibited liquid carrier for a biocide containing a carbodiimide and an emulsifier mixture

Also Published As

Publication number Publication date
EP1313707B1 (en) 2007-07-18
CA2418832A1 (en) 2002-02-14
US7186840B2 (en) 2007-03-06
US7049325B2 (en) 2006-05-23
BR0113175A (pt) 2004-02-17
JP2004505951A (ja) 2004-02-26
CN1199950C (zh) 2005-05-04
US20020082276A1 (en) 2002-06-27
WO2002012192A1 (en) 2002-02-14
CN1466575A (zh) 2004-01-07
MXPA03001178A (es) 2003-06-30
KR20030027016A (ko) 2003-04-03
US20060084677A1 (en) 2006-04-20
EP1313707A1 (en) 2003-05-28
ATE367379T1 (de) 2007-08-15
DE60129445D1 (de) 2007-08-30
ES2290161T3 (es) 2008-02-16
ZA200300847B (en) 2004-04-30
JP3930428B2 (ja) 2007-06-13
AU2001277560A1 (en) 2002-02-18
DE60129445T2 (de) 2008-04-24

Similar Documents

Publication Publication Date Title
RU2221790C2 (ru) Новые производные пиридазина и лекарственные средства, содержащие их в качестве эффективных ингредиентов
ES2521672T3 (es) Formulaciones farmacéuticas para el tratamiento del cáncer
RU2397168C2 (ru) Производные тиофена в качестве ингибиторов снк 1
RU2360912C2 (ru) Замещенные дигидрохиназолины с противовирусными свойствами
AR035371A1 (es) Aminotiazoles, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de un medicamento
BRPI0407329A (pt) Derivados de pirimidina para a prevenção de infecção de hiv
BR0317294A (pt) Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com a glicogênio sintase quinase-3 e de prevenção e/ou tratamento de doenças, e, uso dos intermediários
AR030959A1 (es) Derivados de aminoalcoholes, procedimiento para prepararlos, el uso de los mismos para preparar medicamentos y las composiciones farmaceuticas que las contienen
TW200745029A (en) Sulfonamide derivatives exhibiting PGD2 receptor antagonism
AR036032A1 (es) Compuesto derivado de quinolina, composicion que lo comprende; uso del mismo en la fabricacion de medicamentos, proceso para prepararlo, y metodo para detectar y seleccionar un agente que module la actividad del mif
JP2019521988A5 (cg-RX-API-DMAC7.html)
JP2007519649A5 (cg-RX-API-DMAC7.html)
AR061584A1 (es) Uso de 2-aminotetralinas sustituidas para la fabricacion de un medicamento para la prevencion, alivio y/o tratamiento de diversos tipos de dolor
CO6220933A2 (es) Formulaciones de dosis unitaria y metdods para el tratamiento de la trombosis con un inhibidor oral del facror xa
PA8550201A1 (es) Analogos de prostaglandina
HUP0400314A2 (hu) Gyógyszer-kombinációk rák kezelésére
AR029151A1 (es) Una sal cuaternaria de piperidina, su uso, un proceso para su preparacion, y una composicion farmaceutica que la contiene
AR012489A1 (es) Tiofenopiridinas antagonistas del factor de liberacion de corticotropina. procedimiento para su preparacion, el uso de las mismas en la preparacionde un medicamento, composicion farmaceutica que las comprende, procedimiento para la preparacion de dicha composicion, un compuesto intermediario y
SE9901573D0 (sv) New compounds
AR033554A1 (es) Un compuesto derivado de quinolina, su uso, procedimientos para su preparacion, y un medicamento que lo comprende
AR049711A1 (es) Compuestos heterociclicos condensados como inhibidores de la aldosterona sintasa; composiciones farmaceuticas que los contienen y su uso en la preparacion de un medicamento para el tratamiento o prevencion de enfermedades relacionadas con el hiperaldosterismo y por una liberacion excesiva de cortiso
JP2005526773A5 (cg-RX-API-DMAC7.html)
AR040274A1 (es) Derivados de 1-[(indol-3-il)carbonil]piperazina como agonistas de canabinoides en el tratamiento del dolor y composiciones farmaceuticas
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
DK0570294T3 (da) 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel

Legal Events

Date Code Title Description
FA Abandonment or withdrawal